Women who used a GLP-1 prior to pregnancy and stopped therapy 1 to 2 years before delivery had increased risk for preeclampsia, but reduced risk for developing gestational diabetes, according to study ...
3d
Navigating Regulatory Headwinds: Hims & Hers Balances Growth Ambitions with Legislative Challenges
Undeterred by domestic regulatory concerns, Hims & Hers is actively executing its global strategy. On December 10, the company launched its comprehensive weight-loss program in the United Kingdom, ...
From cereal and granola to snacks and soda, Big Chalk’s Fall 2025 report outlines where GLP-1 users are cutting back - and ...
Tantalizing results from small trials and anecdotes raised hopes that drugs like Ozempic could help. Despite setbacks, ...
Danish researchers were examining the use of medications during and after pregnancy when they noticed a clear trend: The number of women using weight-loss drugs like Ozempic and Wegovy soon after ...
Nagpur: Baban Taywade, national president of OBC Mahasangh, on Wednesday filed an objection that Nagpur Municipal Corporation (NMC) used inconsistent criteria while calculating reservation percentages ...
CHICAGO, Nov 25 (Reuters) - Novo Nordisk's (NOVOb.CO), opens new tab highly anticipated but ultimately unsuccessful Alzheimer's trials were a long shot for the maker of blockbuster drugs Ozempic and ...
Brown-Forman (BF.B) stock may underperform safer investments. Dividend yield and perceived safety do not compensate for the ...
GLP-1 drugs for pets could be the next frontier for the blockbuster weight loss and diabetes drugs. By Emily Anthes In just a few short years, new diabetes and weight loss drugs like Ozempic, Wegovy ...
A new weight loss pill has shown promise as a more convenient medication for adults with obesity and type 2 diabetes. The once-daily pill appears to be effective and safe for these patients, according ...
A growing share of lower-income Americans are struggling to get by financially as their wages fail to keep up with inflation, according to a recent analysis. Roughly 29% of lower-income households are ...
Evan Coleman is an Updates Editor on the Credit Cards and Travel Rewards team at Forbes Advisor, showcasing his interest in personal finance and love of travel. He has written for a variety of local ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback